Rafael W Blanco, MD says that the ongoing advances in science and, in particular, genomic profiling continue to make a positive difference for cancer patients, providing the ability to cure many diseases and malignancies that were once incurable. Dr Blanco has extensive experience as a sub-investigator in Phase II clinical trials research. His work has been published in numerous professional journals, including Blood, the Journal of the American Medical Association and the American Journal of Clinical Oncology, and presented at industry conferences.